NanoVation Therapeutics

Private

Vancouver, British ColumbiaHealthcare & Life Scienceshttps://nanovationtx.com/

Last Round

Seed

Nov 19, 2024

Total Funding Raised

$219,000

Company Overview

NanoVation Therapeutics is a biotechnology company that develops a lipid nanoparticle (LNP) platform for nucleic acid delivery to enable genetic medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

lipid nanoparticle deliveryLNP deliveryextrahepatic deliverynucleic acid deliverylong-circulating LNPgenetic medicinemRNA deliverydrug delivery platformgene therapy deliverytissue-specific deliverystealth LNPcustom LNP formulationlcLNPbone marrow targetingsolid tumor deliverymRNA synthesis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NanoVation Therapeutics Comparables

Compare NanoVation Therapeutics with similar companies based on industry and business-model similarity.

NanoVation Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

NanoVation Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Nov 19, 2024
Grant	Sep 29, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Jayesh Kulkarni

Chief Scientific Officer And Co-Founder

Founding Team

NanoVation Therapeutics Investors

Notable investors and investment history

NanoVation Therapeutics investors
Investor	Rounds
Innovate BC	Grant
Convergent Ventures	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 29, 2026
Monthly visitors increased 48% MoM.
Jan 2, 2026
Monthly visitors grew 106% MoM, reaching 4.6K.

View all signals

NanoVation Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

NanoVation Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NanoVation Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver, British Columbia

Employee Range48

Year Founded2020

Last FundingNov 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.